Table 2.
Baseline characteristics of the patients*
| Variables | Avandamet (n = 198) | Metformin (n = 200) |
|---|---|---|
| Age (years) | 51.38 ± 9.57 | 51.25 ± 8.84 |
| Gender (male, %) | 57.7 | 59.8 |
| Diabetic duration (years) | 3.57 ± 3.49 | 2.73 ± 3.10 |
| Body weight (kg) | 74.82 ± 11.18 | 74.67 ± 10.74 |
| Height (cm) | 165.92 ± 8.75 | 164.94 ± 8.62 |
| BMI (kg/m2) | 27.10 ± 2.75 | 27.39 ± 3.06 |
| Waist circumference (cm) | 93.41 ± 8.15 | 93.48 ± 9.30 |
| SBP (mmHg) | 129.98 ± 13.62 | 129.61 ± 15.98 |
| DBP (mmHg) | 80.31 ± 9.72 | 80.97 ± 9.09 |
*Baseline characteristics were comparable between the two groups except for diabetic duration (P = 0.01). BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure.